Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2024-08-13
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention Study on Probiotic Combination Tableted Candy Hangover
NCT06883760
Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease
NCT01501162
Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis
NCT02335632
Effectiveness and Safety of Probiotics in Protecting Liver Function
NCT06607562
The Effect of Probiotic Supplementation
NCT04390347
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single arm
Single group
Treatment
Leuconostoc mesenteroides
Control vs Experiment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Leuconostoc mesenteroides
Control vs Experiment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) between 18.5 and 30 kg/m²
* Individuals with a history of hangover experience
* Adults with normal results in blood tests and vital signs
* No organic gastrointestinal disease found in endoscopy within the past 3 months
* Able to consume one bottle of soju within 30 minutes
* Individuals who have personally signed the informed consent form
Exclusion
* Individuals who have consumed excessive alcohol within the past week
* Individuals who participated in a human clinical trial within the past month
* Individuals taking supplements or medications that may affect alcohol metabolism
* Individuals with alcohol metabolism disorders, diabetes, hypertension, gallstones, pancreatitis, gout, active tuberculosis, gastrointestinal bleeding or surgery, or those with kidney, liver (e.g., hepatitis B/C carriers, alcoholic liver disease), heart, lung, gastrointestinal, or neurological diseases
* Pregnant women or those planning to become pregnant
* Individuals who have taken liver function supplements or similar medications/health products within one month before the study
* Individuals who consumed excessive alcohol within one week prior to study participation
* Any other individuals deemed unsuitable for the study by the principal investigator
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wonju Severance Christian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kyu Jae Lee
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Kyu-Jae Lee
Wŏnju, Gangwon-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMB-2024-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.